Edition:
United States

Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

24.71USD
18 Jan 2017
Change (% chg)

$-0.01 (-0.04%)
Prev Close
$24.72
Open
$24.83
Day's High
$25.05
Day's Low
$24.50
Volume
441,212
Avg. Vol
376,348
52-wk High
$41.69
52-wk Low
$22.67

Select another date:

Fri, Jan 6 2017

BRIEF-Acceleron outlines corporate goals and priorities for 2017

* Plan to initiate new luspatercept phase 2 clinical trials in distinct patient segments in MDS and Beta-Thalassemia

BRIEF-Acceleron Pharma reports Q3 financial and operational results

* Acceleron Pharma reports third quarter 2016 financial and operational results Source text for Eikon: Further company coverage:

BRIEF-Acceleron Pharma Q2 loss per share $0.59

* Acceleron Pharma reports second quarter 2016 financial and operational results

BRIEF-Acceleron Pharma appoints Thomas McCourt to its board

* Acceleron Pharma appoints Thomas McCourt to its board of directors Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Select another date: